| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 43 |
| 1 | DEXAMETHASONE 1.5 MG | 43 |
| 2 | BORTEZOMIB | 38 |
| 3 | LENALIDOMIDE | 26 |
| 4 | CYCLOPHOSPHAMIDE | 25 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 25 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 25 |
| 7 | ADALIMUMAB | 24 |
| 8 | INFLIXIMAB | 19 |
| 9 | PREDNISONE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | WHITE PETROLATUM MINERAL OIL | 1 | 0.0345 |
| 1 | BENZNIDAZOLE | 1 | 0.0098 |
| 2 | DIFLUNISAL | 2 | 0.0025 |
| 3 | DEFLAZACORT | 3 | 0.0012 |
| 4 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 5 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 6 | HYALURONATE SODIUM | 1 | 0.0007 |
| 7 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| 8 | TAFAMIDIS MEGLUMINE | 3 | 0.0006 |
| 9 | TOBRAMYCIN AND DEXAMETHASONE | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 81 |
| 1 | Proteasome Inhibitor [EPC] | 41 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 37 |
| 3 | Thalidomide Analog [EPC] | 29 |
| 4 | Alkylating Drug [EPC] | 25 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 7 | Kinase Inhibitor [EPC] | 14 |
| 8 | Loop Diuretic [EPC] | 14 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 6 | 0.0004 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 7 | 0.0004 |
| 2 | Proteasome Inhibitor [EPC] | 41 | 0.0004 |
| 3 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 5 | Recombinant Human Growth Hormone [EPC] | 4 | 0.0002 |
| 6 | Bismuth [EPC] | 1 | 0.0002 |
| 7 | Alkaloid [EPC] | 4 | 0.0002 |
| 8 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 9 | Allylamine Antifungal [EPC] | 1 | 0.0001 |